Tags

Type your tag names separated by a space and hit enter

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
Biosci Trends. 2020 Mar 16; 14(1):72-73.BT

Abstract

The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.

Authors+Show Affiliations

Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, China.Department of Pharmacy, Qingdao Municipal Hospital, Qingdao, China.Department of Pharmacy, Qingdao Municipal Hospital, Qingdao, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32074550

Citation

Gao, Jianjun, et al. "Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies." Bioscience Trends, vol. 14, no. 1, 2020, pp. 72-73.
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-73.
Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends, 14(1), 72-73. https://doi.org/10.5582/bst.2020.01047
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies. Biosci Trends. 2020 Mar 16;14(1):72-73. PubMed PMID: 32074550.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. AU - Gao,Jianjun, AU - Tian,Zhenxue, AU - Yang,Xu, Y1 - 2020/02/19/ PY - 2020/2/20/pubmed PY - 2020/3/19/medline PY - 2020/2/20/entrez KW - 2019-nCoV KW - COVID-19 KW - SARS-CoV-2 KW - chloroquine KW - pneumonia SP - 72 EP - 73 JF - Bioscience trends JO - Biosci Trends VL - 14 IS - 1 N2 - The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future. SN - 1881-7823 UR - https://www.unboundmedicine.com/medline/citation/32074550/Breakthrough:_Chloroquine_phosphate_has_shown_apparent_efficacy_in_treatment_of_COVID_19_associated_pneumonia_in_clinical_studies_ L2 - https://dx.doi.org/10.5582/bst.2020.01047 DB - PRIME DP - Unbound Medicine ER -